Novo Nordisk will
target launches of its mega popular obesity shot Wegovy in
markets where it already has strong sales of its older
weight-loss drug Saxenda, CEO Lars Fruergaard Jorgensen said, as
it.
The Danish drugmaker is working to convince European governments and insurers to reimburse the drug, seeking to position it as more than a lifestyle drug. Wegovy was launched in the U.S. in June 2021 but it took Novo until December 2022 to make all doses available there because of an initial production problem.
LONDON (Reuters) -The EU s drug regulator said on Friday it would continue to review whether Novo Nordisk s popular weight-loss drug Wegovy could also be .
In battered, hard-to-reach north Gaza, rare aid deliveries get mobbed by desperate, hungry Palestinians and aid workers report seeing people thin and visibly starving with sunken eyes. .
Gaza starves as Israel presses war on Hamas streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.